Artículos por temáticas

Non-motor subtypes in candidates for subthalamic deep brain stimulation for Parkinson's disease

Ducrocq H, Puisieux S, Hopes L, Frismand S, Colnat-Coulbois S, Kyheng M, Rolland AS, Moreau C, Giordana C, Danaila T, Maltête D, Fabbri M, Benatru I, Marques A, Boukbiza OL, Hubsch-Bonneaud C, Rouaud

Parkinsonism Relat Disord. 2025 Sep;138:107945. doi: 10.1016/j.parkreldis.2025.107945. Epub 2025 Jul 18.

Myelopathic motor symptoms overlaying Parkinson's disease

Groves J, Mallon DH, Borg A, Zaidman N, Foltynie T, Limousin P, Mehta AR, Korlipara LVP.

Pract Neurol. 2025 Sep 12;25(5):479-482. doi: 10.1136/pn-2025-004546.

Efficacy and safety of continuous subcutaneous ND0612 Infusion compared to oral and alternative regimens in managing motor fluctuations in Parkinson's disease: a systematic review and meta-analysis

Abunamoos A, Alghaniem MMA, Qtaishat FA, Aljazi Y, Al-Omari LO, Salomon I, Hammadeh BM, Moghib K.

Neurol Sci. 2025 Sep;46(9):4137-4153. doi: 10.1007/s10072-025-08257-w. Epub 2025 Jun 2.

The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence

Raggi A, Serretti A, Ferri R.

Int Clin Psychopharmacol. 2025 Sep 1;40(5):259-274. doi: 10.1097/YIC.0000000000000566. Epub 2024 Aug 21.

Tailoring anxiety assessment for Parkinson's disease: The Chinese Parkinson anxiety scale with cultural and situational anxiety considerations

Poon SF, Tan CH, Hong WP, Chen KC, Yu RL.

Soc Sci Med. 2025 Sep;381:118284. doi: 10.1016/j.socscimed.2025.118284. Epub 2025 Jun 7.

The 2024 UK clinical guideline for the prevention and treatment of osteoporosis

Gregson CL, Armstrong DJ, Avgerinou C, Bowden J, Cooper C, Douglas L, Edwards J, Gittoes NJL, Harvey NC, Kanis JA, Leyland S, Low R, McCloskey E, Moss K, Parker J, Paskins Z, Poole K, Reid DM, Stone M

Arch Osteoporos. 2025 Sep 8;20(1):119. doi: 10.1007/s11657-025-01588-3.

Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention

Mohan D, Venkatesan R, Kandy AT, Muthu S, Jayaram S, Baskaran R, Pethappachetty P, Selvaraj D.

Mol Cell Neurosci. 2025 Sep 9;135:104037. doi: 10.1016/j.mcn.2025.104037. Online ahead of print.

Gut-brain-immune interactions: exploring probiotics as a drug delivery platform for neurological disease

Gudi CR, Wannemuehler MJ, Mansell TJ.

Adv Drug Deliv Rev. 2025 Sep;224:115650. doi: 10.1016/j.addr.2025.115650. Epub 2025 Jul 9.

A Comparative Analysis of Psychiatric Symptoms in Parkinson's Disease Between Tremor-Dominant and Non-Tremor-Dominant Phenotypes

Akan M, Çıplak S, Adıgüzel A.

Neurol India. 2025 Sep 1;73(5):1012-1017. doi: 10.4103/neurol-india.Neurol-India-D-24-00415. Epub 2025 Sep 13.

Nonmotor fluctuations in Parkinson's disease: impact on caregiving and quality of life

Ledda C, Imbalzano G, Scaglia E, Artusi CA, Nicoletti A, Erro R, Rinaldi D, Gallo S, Montanaro E, Zibetti M, Rizzone MG, Balestrino R, Agosta F, Galli S, Sorrentino C, Indaco D, Donzuso G, Terravecchi

J Neurol. 2025 Sep 22;272(9):639. doi: 10.1007/s00415-025-13390-9.

The effect of diet on Parkinson's disease progression, symptoms and severity: a review of randomised controlled trials

Prasad A, Glover C, Shuler MS, Dayal V, Lithander FE.

Proc Nutr Soc. 2025 Aug 29:1-15. doi: 10.1017/S0029665125101213. Online ahead of print.

Parkin, a key player in Parkinson's disease pathogenesis: A review

Malhotra V, Ansari J, Khan S, Khan NJ, Shahid M, Hassan MI, Islam A.

Int J Biol Macromol. 2025 Sep;323(Pt 1):147034. doi: 10.1016/j.ijbiomac.2025.147034. Epub 2025 Aug 21.

The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation-A Narrative Review

Lehoczki A, Fekete M, Jarecsny T, Zábó V, Szappanos Á, Csípő T, Lipécz Á, Major D, Fazekas-Pongor V, Varga P, Varga JT.

Nutrients. 2025 Sep 6;17(17):2884. doi: 10.3390/nu17172884.

Urinary α-Synuclein for Parkinson's Detection: Key Limitations and Future Directions

Ma J, Deng P, Liu S.

Ann Neurol. 2025 Sep;98(3):638. doi: 10.1002/ana.70018. Epub 2025 Aug 11.

The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders

Schindler KA, Torices S, Schurhoff N, Gallo DI, Toborek M.

Adv Drug Deliv Rev. 2025 Sep;224:115645. doi: 10.1016/j.addr.2025.115645. Epub 2025 Jul 2.